Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy
Cancer therapy is still a challenging issue. To address this, the combination of anticancer drugs with other therapeutic modalities, such as light-triggered therapies, has emerged as a promising approach, primarily when both active ingredients are provided within a single nanosystem. Herein, we desc...
Saved in:
Main Authors: | Francesca Moret (Author), Luca Menilli (Author), Manuele Battan (Author), Daniele Tedesco (Author), Marta Columbaro (Author), Andrea Guerrini (Author), Greta Avancini (Author), Claudia Ferroni (Author), Greta Varchi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
by: Jincheng Yang, et al.
Published: (2018) -
Drug Delivery in Photodynamic Therapy
by: Francesca Moret, et al.
Published: (2023) -
Mesenchymal Stem Cell Membrane-Coated TPCS<sub>2a</sub>-Loaded Nanoparticles for Breast Cancer Photodynamic Therapy
by: Greta Avancini, et al.
Published: (2023) -
Two Beats One: Osteosarcoma Therapy with Light-Activated and Chemo-Releasing Keratin Nanoformulation in a Preclinical Mouse Model
by: Elisa Martella, et al.
Published: (2022) -
A review on smart bioresponsive drug delivery systems
by: Kainat Haleem, et al.
Published: (2019)